CAS 780758-10-3

Nimotuzumab

CAS: 780758-10-3

Intereferes with EGFR ligand binding; cancer therapy

Reinheit: Min. 95%

Farbe und Form: Clear Liquid

Ref: 3D-BN165591

Nimotuzumab (powder)

CAS: 780758-10-3

Nimotuzumab (powder) is a humanized IgG1 monoclonal antibody that specifically targets the epidermal growth factor receptor (EGFR), possessing a dissociation constant (KD) of 0.21 nM. It blocks the binding to its ligand by targeting the extracellular domain of EGFR. Nimotuzumab exhibits strong antitumor activity by inducing both antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), exerting cytolytic effects on target tumors.

Farbe und Form: Liquid

Ref: TM-T9901A-1025